| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.07 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |